Financials MedApp S.A.

Equities

MDA

PLYLWHT00012

Software

End-of-day quote Warsaw S.E. 03:30:00 15/05/2024 am IST 5-day change 1st Jan Change
0.339 PLN +2.73% Intraday chart for MedApp S.A. +2.42% -1.45%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 207.1 94.18 200.3 245.9 235.1 97.55
Enterprise Value (EV) 1 207.1 93.45 200.3 245.1 235 97.81
P/E ratio -128 x -39.8 x 298 x 130 x 61.7 x 163 x
Yield - - - - - -
Capitalization / Revenue 1,091 x 761 x 62.1 x 40.8 x 18.5 x 14.5 x
EV / Revenue 1,091 x 755 x 62.1 x 40.7 x 18.5 x 14.5 x
EV / EBITDA -107 x -60.4 x 225 x 95.9 x 40.7 x 31.8 x
EV / FCF -154 x -76.2 x -21.4 x 108 x -215 x -95.1 x
FCF Yield -0.65% -1.31% -4.67% 0.93% -0.46% -1.05%
Price to Book 34 x 16.4 x 12.3 x 12.1 x 9.64 x 3.59 x
Nbr of stocks (in thousands) 1,25,500 1,38,500 2,37,089 2,47,161 2,50,132 2,50,132
Reference price 2 1.650 0.6800 0.8450 0.9950 0.9400 0.3900
Announcement Date 30/05/18 31/05/19 30/06/20 22/03/21 29/04/22 31/05/23
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.1899 0.1238 3.226 6.025 12.71 6.733
EBITDA 1 -1.939 -1.548 0.8904 2.557 5.777 3.078
EBIT 1 -2.276 -1.945 0.5485 2.116 5.28 1.28
Operating Margin -1,198.95% -1,571.32% 17% 35.12% 41.55% 19.01%
Earnings before Tax (EBT) 1 -2.209 -2.006 0.4698 1.874 4.112 1.199
Net income 1 -1.615 -2.365 0.6731 1.915 3.813 0.609
Net margin -850.65% -1,910.59% 20.87% 31.79% 30% 9.05%
EPS 2 -0.0129 -0.0171 0.002839 0.007659 0.0152 0.002400
Free Cash Flow 1 -1.349 -1.227 -9.354 2.268 -1.091 -1.029
FCF margin -710.7% -991.13% -289.95% 37.64% -8.58% -15.28%
FCF Conversion (EBITDA) - - - 88.71% - -
FCF Conversion (Net income) - - - 118.42% - -
Dividend per Share - - - - - -
Announcement Date 30/05/18 31/05/19 30/06/20 22/03/21 29/04/22 31/05/23
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.07 - - - - 0.26
Net Cash position 1 - 0.73 0.07 0.78 0.13 -
Leverage (Debt/EBITDA) -0.0376 x - - - - 0.0841 x
Free Cash Flow 1 -1.35 -1.23 -9.35 2.27 -1.09 -1.03
ROE (net income / shareholders' equity) -28.4% -40% 6.13% 10.4% 17% 2.27%
ROA (Net income/ Total Assets) -16% -10.7% 2.17% 6.3% 12.5% 2.48%
Assets 1 10.09 22.18 31.03 30.4 30.47 24.6
Book Value Per Share 2 0.0500 0.0400 0.0700 0.0800 0.1000 0.1100
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 1.97 0.07 - 0.11 0.24 6.52
Capex / Sales 1,038.85% 60.29% - 1.91% 1.89% 96.79%
Announcement Date 30/05/18 31/05/19 30/06/20 22/03/21 29/04/22 31/05/23
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

1st Jan change Capi.
-1.45% 2.16Cr
-18.65% 22TCr
-8.97% 6.67TCr
-2.52% 5.69TCr
-9.54% 4.71TCr
-2.40% 3.96TCr
-6.72% 3.41TCr
-9.09% 2.88TCr
+110.94% 2.77TCr
+5.08% 2.2TCr
Application Software
  1. Stock Market
  2. Equities
  3. MDA Stock
  4. Financials MedApp S.A.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW